Bunge unveils new soy protein line backed by US$550 million investment and major facility expansion

Bunge launched a new line of soy protein concentrates at IFFA last week, part of its strategy to provide food and beverage manufacturers with high-quality, scalable plant-protein solutions. The concentrates – set to hit the market this fall – are designed to overcome common barriers in plant-based formulation, offering a clean taste, neutral color, and cost-effective profile.

The new products will be manufactured at Bunge’s soon-to-be-completed facility in Morristown, Indiana, which the company says will become the world’s largest food-grade plant protein site. The US$550 million investment into the facility reflects Bunge’s commitment to meeting growing global demand for plant-based protein while improving sustainability and supply chain efficiency.

With around 70% protein and 17% fiber content on a dry basis, the concentrates will be available in both conventional and non-GMO formats. They’ll be offered in powdered and textured forms suitable for use in snacks, baked goods, plant-based meats, and beverages.

Affordability has been a key focus in developing the new line. “A lot of [our customers] in the plant-based meat world are trying to make sure that they can achieve price parity between alt-meat products and animal meat products,” Mark Stavro, Director of Marketing for Global Emulsifiers & Proteins at Bunge told Food Ingredients First. “By giving them an affordable product, they are able to hit that price parity and grow their business much more profitably.”

The Morristown site will also enhance Bunge’s ability to scale production while maintaining close partnerships with local farmers practicing regenerative agriculture. The facility’s energy-efficient systems contribute to a reduced carbon footprint, aligning with the sustainability goals of many of Bunge’s partners and clients.